- Subjects are hospitalized males and females, aged 13 years or older, with clinical
evidence of complicated skin and skin structure bacterial infection with material
suitable for culture from 1 primary site of infections
- Within 72 hours before enrollment or at the time of enrollment, all subjects must
provide an appropriate specimen for culture and susceptibility testing
- Subjects who have been given prior antibacterial therapy within 14 days of trial entry
may be entered only if a culture is obtained showing persistence of a pathogen in
blood or at the site of infection
- Subjects with a known or suspected hypersensitivity to cephalosporins, penicillins, or
carbapenems
- Subjects with a history of seizure disorders or subjects currently receiving
antiepileptic medication
- Subjects with underlying infections or conditions which would interfere with
evaluation of this study